CompletedNot Applicable

Efficiency of Intercoat (Oxiplex/AP Gel)in Decreasing Intrauterine Adhesions

Israel60 participantsStarted 2009-09

Plain-language summary

This is a prospective single blind randomized controlled pilot study was designed to investigate whether the biological barrier Intercoat (Oxiplex/AP gel) reduces formation of intrauterine adhesions following hysteroscopic treatment for retained products of conception.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 18 and 50 years * Availability of the results of vaginal ultrasound or diagnostic hysteroscopy Exclusion Criteria: * Signs of infection upon admission * Ongoing pregnancy

What they're measuring

safety of intrauterine application of Intercoat

Timeframe: 18 months

Trial details

NCT IDNCT01377779

SponsorAssaf-Harofeh Medical Center

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2010-11

View on ClinicalTrials.gov More Asherman Syndrome trials